| Literature DB >> 36013533 |
Bogdan Doroftei1,2,3, Ovidiu-Dumitru Ilie4, Ana-Maria Dabuleanu1,2,3, Delia Hutanu5, Constantin-Cristian Vaduva6,7,8.
Abstract
Background: Infertility is a global burden that affects both sexes with the male component remaining as an explored yet crucial research field that might offer novel evidence. Material andEntities:
Keywords: male infertility; microflora; semen; seminal fluid; sperm; spermatozoa
Mesh:
Substances:
Year: 2022 PMID: 36013533 PMCID: PMC9414835 DOI: 10.3390/medicina58081067
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.948
Summarization of the studies in which the authors sequenced the 16S rRNA in human individuals.
| Number of Participants | Hypervariable Region | Sequencer | Microbial Changes | Reference |
|---|---|---|---|---|
| V3–V6 | Ion PGM | [ | ||
| V3–V5 | 454-GS Junior | [ | ||
| V1–V2 | MiSeq | [ | ||
| V3–V4 | MiSeq | [ | ||
| V1–V2 | HiSeq 2500 | [ | ||
| V2–V3 | 454 FLX | [ | ||
| V3–V4 | MiSeq | [ | ||
| V3–V4 | MiSeq | [ | ||
| V4 | MiSeq | [ |
↑—increase; ↓—decrease; ↑↓—variations rely on the study design/patient allocations.
Summarization of the studies in which the authors sequenced the 16S rRNA in zebrafish.
| Hypervariable Regions | Sequencer | Microbiota Changes | Reference |
|---|---|---|---|
| V3–V4 | Miseq PE300 | [ | |
| V3–V4 | Miseq PE300 | [ |
↑—increase; ↓—decrease.
Summarization of the studies in which the authors sequenced the 16S rRNA in rats.
| Model | Hypervariable Regions | Sequencer | Microbiota Changes | Reference |
|---|---|---|---|---|
| Wistar, Sprague-Dawley | V3–V4 | MiSeq PE300 | [ | |
| Sprague-Dawley | V3–V4 | MiSeq | [ | |
| Sprague-Dawley | V4 | HiSeq 2500 | [ | |
| Sprague-Dawley | 338F–806R | - | ||
| Sprague-Dawley | V4 | HiSeq 2000 | - | [ |
↑—increase; ↓—decrease; ↑↓—variations rely on the study design/patient allocations.
Summarization of the studies in which the authors sequenced the 16S rRNA in mice.
| Model | Hypervariable Region | Sequencer | Microbiota Changes | Reference |
|---|---|---|---|---|
| C57BL/6 | V3–V4 | HiSeq 4000 | [ | |
| C57BL/6J | V4 | MiSeq | [ | |
| C57BL/6J | V3–V4 | HiSeq 6000 | [ | |
| KK-Ay C57BL/6J | V3–V4 | MiSeq | [ | |
| KK-Ay C57BL/6 | V3–V4 | MiSeq | [ | |
| CD-1 | V3–V4 | HiSeqTM 2500 | [ | |
| C57BL/6 | V4 | MiSeq | [ | |
| ICR | V3–V4 | HiSeq X Ten | [ | |
| BALB/c | V3–V4 | MiSeq | [ | |
| C57BL/6J | V3–V4 | MiSeq | [ |
↑—increase; ↓—decrease; ↑↓—variations rely on the study design/patient allocations.